GRDN | tickerfilter.com

Fundamental analysis

17%

Profitability 0%

Dept financing 20%

Liquidity 27%

Performance 30%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-3.53%

1 Month

11.59%

3 Months

2.50%

6 Months

11.84%

1 Year

28.13%

2 Year

28.13%

Key data

Stock price

$20.50

P/E Ratio

N/A

DAY RANGE

$20.20 - $21.68

EPS

-$2.00

52 WEEK RANGE

$14.16 - $25.74

52 WEEK CHANGE

$28.12

MARKET CAP

0.000

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

05-15-2025

BETA

2.19

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$118,240

AVERAGE 30 VOLUME

$110,621

Company detail

CEO: Fred P. Burke
Region: US
Website: guardianpharmacy.com
Employees: 0
IPO year: 2024

Issue type:
Market: NYSE
Industry: Retail/Retail – Drug & Proprietary Stores
Sector: Retail Trade

We are a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of long-term health care facilities (“LTCFs”) adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. Our principal executive offices are located at 300 Galleria Parkway SE, Suite 800, Atlanta, Georgia.

GRDN - Guardian Pharmacy Services, Inc.